Man, Jelle P. https://orcid.org/0000-0003-2040-3686
Koole, Maarten A. C. https://orcid.org/0000-0002-0437-7329
Meregalli, Paola G.
Handoko, M. Louis https://orcid.org/0000-0002-8942-7865
Stienen, Susan https://orcid.org/0000-0002-5573-9377
de Lange, Frederik J. https://orcid.org/0000-0002-7590-9230
Winter, Michiel M.
Schijven, Marlies P. https://orcid.org/0000-0001-7013-0116
Kok, Wouter E. M. https://orcid.org/0000-0002-7789-6285
Kuipers, Dorianne I.
van der Harst, Pim https://orcid.org/0000-0002-2713-686X
Asselbergs, Folkert W. https://orcid.org/0000-0002-1692-8669
Zwinderman, Aeilko H. https://orcid.org/0000-0003-0361-3139
Dijkgraaf, Marcel G. W. https://orcid.org/0000-0003-0750-8790
Chamuleau, Steven A. J. https://orcid.org/0000-0002-9952-6701
Schuuring, Mark J. https://orcid.org/0000-0002-2843-1852
Funding for this research was provided by:
This investigator-initiated study was funded by the Amsterdam University Medical Center without any contribution from an industrial partner.
Article History
Received: 2 July 2024
Accepted: 7 August 2024
First Online: 31 August 2024
Change Date: 4 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-024-03322-x
Competing interests
: M.L.H. is supported by the Dutch Heart Foundation (Dr. E. Dekker Senior Clinical Scientist Grant 2020T058) and CVON (2020B008 RECONNEXT). M.L.H. received an investigator-initiated research grant from Vifor Pharma; an educational grant from Boehringer Ingelheim and Novartis; and speaker/consultancy fees from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Merck Sharp & Dohme, Novartis, Daiichi Sankyo, Quin and Vifor Pharma. W.E.M.K. received a speaking fee from Novartis. F.W.A. received grant funding from the European Union Horizon scheme (AI4HF 101080430 and DataTools4Heart 101057849). M.J.S. received an independent research grant from AstraZeneca to the research institute. The other authors declare no competing interests.